Picloram

Picloram

SCHEMBL5086801

Nc1c(Cl)c(Cl)nc(C(=O)O)c1Cl.O=C(O)O

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Picloram. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.96
MAPT P10636 3/20 0.47
LMNA P02545 3/20 0.47
GAA P10253 3/20 0.47
ATM Q13315 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
NOX1 Q9Y5S8 1/20 0.38
KMO O15229 1/20 0.35
HCAR2 Q8TDS4 1/20 0.34
ALDH1A1 P00352 4/20 0.34
KDM4E B2RXH2 3/20 0.34
GLA P06280 3/20 0.34
HPGD P15428 3/20 0.34
HSD17B10 Q99714 3/20 0.34
PLAU P00749 2/20 0.34
CYP1A2 P05177 2/20 0.34
SLC9A1 P19634 2/20 0.34
SLC22A1 O15245 1/20 0.34
HTR1A P08908 1/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Picloram SCHEMBL13299 0.98 TDP1 (1.00) TDP1MAPTLMNAGAAATM
Picloram SCHEMBL8467014 0.98 TDP1 (1.00) TDP1MAPTLMNAGAAATM
Picloram SCHEMBL29388079 0.98 TDP1 (1.00) TDP1MAPTLMNAGAAATM
Picloram SCHEMBL7112378 0.96 TDP1 (0.96) TDP1MAPTLMNAGAAATM
Picloram SCHEMBL29705200 0.96 TDP1 (0.96) TDP1MAPTLMNAGAAATM
Picloram SCHEMBL18112562 0.96 TDP1 (0.96) TDP1MAPTLMNAGAAATM
Picloram SCHEMBL724603 0.96 TDP1 (0.96) TDP1MAPTLMNAGAAATM
Picloram SCHEMBL28547325 0.96 TDP1 (0.96) TDP1MAPTLMNAGAAATM
Picloram SCHEMBL15437675 0.96 TDP1 (0.96) TDP1MAPTLMNAGAAATM
Picloram SCHEMBL4936972 0.92 TDP1 (0.89) TDP1MAPTLMNAGAAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2990112-B1 METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE MARUZEN PETROCHEM CO LTD (JP) 2020-03-25 EP disclosed
EP-2990113-B1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS MARUZEN PETROCHEM CO LTD (JP) 2020-03-25 EP disclosed
EP-3150588-B1 APPARATUS AND METHOD FOR PRODUCING CYCLIC CARBONATE MARUZEN PETROCHEM CO LTD (JP) 2019-07-03 EP disclosed
US-10106520-B2 Apparatus and method for producing cyclic carbonate MARUZEN PETROCHEMICAL CO., LTD. (JP) 2018-10-23 US disclosed
US-10029241-B2 Method for producing catalyst for cyclic carbonate synthesis MARUZEN PETROCHEMICAL CO., LTD. (JP) 2018-07-24 US disclosed
EP-3023418-B1 METHOD FOR MANUFACTURING CYCLIC CARBONATE AIST (JP) 2018-07-11 EP disclosed
US-10011621-B2 Method for producing silica gel-immobolized phosphonium salt catalysts MARUZEN PETROCHEMICAL CO., LTD. (JP) 2018-07-03 US disclosed
EP-3023419-B1 METHOD FOR CONTINUOUSLY PRODUCING CYCLIC CARBONATE MARUZEN PETROCHEM CO LTD (JP) 2018-01-31 EP disclosed
US-9856229-B2 Method for producing cyclic carbonate NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2018-01-02 US disclosed
US-9834536-B2 Method for producing catalyst for cyclic carbonate synthesis NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2017-12-05 US disclosed
US-20160145234-A1 METHOD FOR PRODUCING CYCLIC CARBONATE NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2016-05-26 US disclosed
EP-3023419-A1 METHOD FOR CONTINUOUSLY PRODUCING CYCLIC CARBONATE Maruzen Petrochemical Co., Ltd. (JP) 2016-05-25 EP disclosed
EP-3023418-A1 METHOD FOR MANUFACTURING CYCLIC CARBONATE National Institute of Advanced Industrial Science and Technology (JP) 2016-05-25 EP disclosed
US-20160108071-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS MARUZEN PETROCHEMICAL CO., LTD. (JP) 2016-04-21 US disclosed
US-20160067695-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS MARUZEN PETROCHEMICAL CO., LTD. (JP) 2016-03-10 US disclosed
US-20160060242-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2016-03-03 US disclosed
EP-2990114-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS National Institute of Advanced Industrial Science and Technology (JP) 2016-03-02 EP disclosed
EP-2990113-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS Maruzen Petrochemical Co., Ltd. (JP) 2016-03-02 EP disclosed
EP-2990112-A1 METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE Maruzen Petrochemical Co., Ltd. (JP) 2016-03-02 EP disclosed
US-20080214386-A1 Stability; easily separated from solution; surface treatment of catalyst with Group seven compound; reacting epoxide with carbon dioxide NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160067695-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS CYCS, CA7, CA9 TDP1 4293/4885MAPT 4547/4885LMNA 3426/4885
US-10029241-B2 Method for producing catalyst for cyclic carbonate synthesis CYCS, CA7, CA9 TDP1 4293/4885MAPT 4547/4885LMNA 3426/4885
US-20160145234-A1 METHOD FOR PRODUCING CYCLIC CARBONATE CA7, CA2, CA4 TDP1 2980/4885MAPT 4745/4885LMNA 3039/4885
US-20160108071-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS EPHX2, CA4, CA9 TDP1 4480/4885MAPT 4840/4885LMNA 1304/4885
US-10106520-B2 Apparatus and method for producing cyclic carbonate SCO2, CA2, AGL TDP1 4184/4885MAPT 3823/4885LMNA 3569/4885
US-20160060242-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS CA2, PLCB3, PHOSPHO1 TDP1 4666/4885MAPT 4859/4885LMNA 1548/4885
US-10011621-B2 Method for producing silica gel-immobolized phosphonium salt catalysts SIK2, SIK3, SIK1 TDP1 3328/4885MAPT 4741/4885LMNA 1871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.